People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Biotechnology, Pharma, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Neurona Therapeutics, Inc | — | Biotechnology | Series D+ | $347.5M | $874.2M | 2025 |
| Constellation Pharmaceuticals Inc | — | Biotechnology | Series C | $286.4M | $2.7B | 2018 |
| Circle Pharma, Inc. | — | Pharma | Series C | $177.6M | $810.6M | 2021 |
| Aragon Pharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $141.5M | $1.8B | 2009 |
Peter Svennilson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Peter Svennilson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Goeddel | 2 | 10 |
| Peter A. Svennilson | 2 | 2 |
| Carl Gordon | 1 | 24 |
| Tim Kutzkey | 1 | 7 |
| MATTHEW JACOBSON | 1 | 6 |
| Anthony Evnin | 1 | 6 |
| Leo - Guthart | 1 | 4 |
| Elton Satusky | 1 | 4 |
| John Josey | 1 | 3 |
| Erica Whittaker | 1 | 3 |
| Robert Tjian | 1 | 3 |
| Keith Dionne | 1 | 3 |
| Mark A. Goldsmith | 1 | 2 |
| Thilo Schroeder | 1 | 2 |
| Robert E. Tepper | 1 | 2 |
| Richard A. Heyman | 1 | 2 |
| Jigar Raythatha | 1 | 2 |
| Brad Margus | 1 | 2 |
| Peter P. Svennilson | 1 | 2 |
| James Stutz | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.